The bench scientist’s perspective on the unique considerations in nanoparticle regulation

Bryce J. Marquis; Melissa A. Maurer-Jones; Özlem H. Ersin; Yu Shen Lin; Christy L. Haynes; Ozlem Ersin

doi:10.1007/s11051-011-0251-0

The bench scientist’s perspective on the unique considerations in nanoparticle regulation

Bryce J. Marquis
, Melissa A. Maurer-Jones
, Özlem H. Ersin
, Yu Shen Lin
, Christy L. Haynes
, Ozlem Ersin

Eastern Illinois University

University of Minnesota

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Nanoparticle Research
Volume	13
DOIs	https://doi.org/10.1007/s11051-011-0251-0
State	Published - Apr 1 2011

Disciplines

Materials Science and Engineering
Nanotechnology

Access to Document

10.1007/s11051-011-0251-0License: Unspecified

Cite this

@article{29b171dc71a640df95a4cbe3f9b812db,

title = "The bench scientist{\textquoteright}s perspective on the unique considerations in nanoparticle regulation",

author = "Marquis, \{Bryce J.\} and Maurer-Jones, \{Melissa A.\} and Ersin, \{{\"O}zlem H.\} and Lin, \{Yu Shen\} and Haynes, \{Christy L.\} and Ozlem Ersin",

note = "The emergence and use of nanotechnologies in commercially available products, including nanotherapeutics, have necessitated the response of regulatory agencies to ensure that these products are safely employed. While bench scientists are at the forefront of nanoparticle development and design, many are unaware of the regulatory requirements necessary to transform their laboratory discoveries into marketable products.",

year = "2011",

month = apr,

day = "1",

doi = "10.1007/s11051-011-0251-0",

language = "American English",

volume = "13",

journal = "Journal of Nanoparticle Research",

}

TY - JOUR

T1 - The bench scientist’s perspective on the unique considerations in nanoparticle regulation

AU - Marquis, Bryce J.

AU - Maurer-Jones, Melissa A.

AU - Ersin, Özlem H.

AU - Lin, Yu Shen

AU - Haynes, Christy L.

AU - Ersin, Ozlem

N1 - The emergence and use of nanotechnologies in commercially available products, including nanotherapeutics, have necessitated the response of regulatory agencies to ensure that these products are safely employed. While bench scientists are at the forefront of nanoparticle development and design, many are unaware of the regulatory requirements necessary to transform their laboratory discoveries into marketable products.

PY - 2011/4/1

Y1 - 2011/4/1

UR - https://experts.umn.edu/en/publications/the-bench-scientists-perspective-on-the-unique-considerations-in-

U2 - 10.1007/s11051-011-0251-0

DO - 10.1007/s11051-011-0251-0

M3 - Article

VL - 13

JO - Journal of Nanoparticle Research

JF - Journal of Nanoparticle Research

ER -

The bench scientist’s perspective on the unique considerations in nanoparticle regulation

Disciplines

Access to Document

Other files and links

Cite this